(PharmaNewsWire.Com, April 22, 2021 ) The report "Medical Decision Support Systems for Sepsis Market Revolutionary Primer for Clinical Decision Support (Market Dynamics, Case Studies, Regional Analysis (North America, Europe, Asia Pacific, Rest of the World)) - Global Forecast to 2022", the medical decision support systems market is expected to reach USD 35.6 Million, at a CAGR of 24.3%.
What Drives the Market Growth?
The key factors driving the growth of this market include increasing funding and research grants, growing pressure to curb healthcare spending, and improving patient outcomes.
- To define, describe, and forecast the global medical decision support systems for sepsis market on the basis of region
- To provide detailed information regarding the major factors influencing the growth of the market (drivers, restraints, opportunities, and challenges)
- To analyze micromarkets with respect to individual growth trends, future prospects, and contributions to the overall market
- To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
- To forecast the size of the market segments with respect to four main regions, namely, North America, Europe, Asia Pacific, and the Rest of the World
Increasing funding & research grants, growing pressure to curb healthcare spending, and improving patient outcomes are the major factors propelling the growth of the market. In addition, machine learning & artificial intelligence in CDSS is posing as a lucrative opportunity for the market in the coming years.
Various players in the market offer sepsis CDS solutions embedded in their EHR while there are others who offer separate surveillance solutions for sepsis.
The North American market accounted for the largest share in 2017 and is expected to register the highest CAGR during the forecast period. The large share and high growth can be attributed to factors such as increasing efforts to curb healthcare spending, federal initiatives such as the Hospital Readmissions Reduction Program, and rising investments in HCIT solutions in the country. Major players providing sepsis CDS modules include Cerner, Epic, and MEDITECH. Third-party vendors like VigiLanz, Iatric Systems, and PeraHealth are also based out of the US. The presence of these key players in the country has made the US a center of innovation in the CDSS market. Moreover, growing awareness regarding the use of HCIT solutions for sepsis management, high number of installations of CDS solutions, and various studies have been conducted to check benchmark for the efficacy of different solutions in the US.
Europe accounted for second largest share of the market and followed by Asia Pacific
Global Key Leaders:
Wolters Kluwer Health (US), Cerner Corporation (US), Philips Healthcare (Netherlands), Amara Health Analytics (US), McKesson Corporation (US), Ambient Clinical Analytics (US), Iatric Systems Inc. (US), PeraHealth Inc. (US), Health Catalyst Inc. (US), and Allscripts Healthcare Solutions, Inc. (US) are the key players in the global medical decision support systems for sepsis market.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
